Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for SVRA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2001. Start Trial.
Date Value
June 30, 2026 205.40M
March 31, 2026 204.92M
December 31, 2025 204.57M
September 30, 2025 172.85M
June 30, 2025 172.84M
March 31, 2025 172.70M
December 31, 2024 172.42M
September 30, 2024 170.84M
June 30, 2024 138.20M
March 31, 2024 138.18M
December 31, 2023 138.14M
September 30, 2023 135.34M
June 30, 2023 114.15M
March 31, 2023 114.06M
December 31, 2022 114.05M
September 30, 2022 114.04M
June 30, 2022 114.04M
March 31, 2022 114.04M
December 31, 2021 114.04M
September 30, 2021 113.87M
June 30, 2021 113.85M
March 31, 2021 113.58M
December 31, 2020 54.15M
September 30, 2020 54.14M
June 30, 2020 52.82M
Date Value
March 31, 2020 50.84M
December 31, 2019 50.79M
September 30, 2019 41.21M
June 30, 2019 38.90M
March 31, 2019 35.83M
December 31, 2018 35.15M
September 30, 2018 35.12M
June 30, 2018 30.84M
March 31, 2018 30.60M
December 31, 2017 30.51M
September 30, 2017 24.39M
June 30, 2017 24.20M
March 31, 2017 3.661M
December 31, 2016 3.163M
September 30, 2016 3.327M
June 30, 2016 2.976M
March 31, 2016 2.755M
December 31, 2015 2.337M
September 30, 2015 2.337M
June 30, 2015 2.337M
March 31, 2015 2.278M
December 31, 2014 2.278M
September 30, 2014 1.822M
June 30, 2014 1.712M
March 31, 2014 1.625M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Gilead Sciences, Inc. 1.241B
Insmed, Inc. 218.28M
United Therapeutics Corp. 42.68M
Vertex Pharmaceuticals, Inc. 253.35M
SELLAS Life Sciences Group, Inc. 201.92M